Patient responses to ipilimumab, a novel immunopotentiator for metastatic melanoma: how different are these from conventional treatment responses? (Q37845097)

From Wikidata
Jump to navigation Jump to search
scientific article published on December 2012
edit
Language Label Description Also known as
English
Patient responses to ipilimumab, a novel immunopotentiator for metastatic melanoma: how different are these from conventional treatment responses?
scientific article published on December 2012

    Statements

    Patient responses to ipilimumab, a novel immunopotentiator for metastatic melanoma: how different are these from conventional treatment responses? (English)
    Gregory K Pennock
    William Waterfield
    1 December 2012
    606-611

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit